It's harder for younger children to deal with the complexities of managing type 1 diabetes (T1D), so a delayed diagnosis even by a few years is a big deal, said Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine.
Despite improvements in type 1 diabetes (T1D) care, such as insulin pumps and glucose monitors, the condition still impacts everyday life, so it's important to delay the diagnosis of it, said Kevan Herold, MD, professor of immunobiology and medicine at Yale School of Medicine.
Transcript
Can you explain the importance of delaying T1D diagnosis?
So the question is, is it better not to have diabetes than have diabetes? The answer is, it's better not to have diabetes. Diabetes is with you 24/7; it disrupts your life, your family's life, everyone who lives with you; it never goes away. The care of the disease has improved, there's absolutely no question about that, but individuals with diabetes basically are on their disease 24/7. There's nothing you do without thinking about it.
If you're a child, and you're 8 years old, and now you're not going to get diabetes until you're 15, that's a big deal. Because younger children are going to have a harder time dealing with all the complexities of managing the disease. It affects diet, it affects activity, it affects sleep, it affects work, it affects school—everything. To be a little bit older, or a lot older, is definitely going to help your ability to manage it. And for the families, it's a blessing not to have the disease.
The question is important. My response is, there are some people—endocrinologists, in particular—who think, "Oh, it's just fine. We have insulin pumps and we have glucose monitors. Who cares if you have diabetes?" That's not true. It matters whether or not you have diabetes.
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
How Mirdametinib Improves QOL for People With NF1-Associated Plexiform Neurofibromas
March 18th 2025Christopher L. Moertel, MD, University of Minnesota, discusses the trial data that helped get mirdametinib approved and what providers can do to keep measuring quality of life (QOL) improvements.
Read More
Advances in Gene Therapy, Neuroregeneration at the Forefront of MDA 2025
March 13th 2025Look ahead to this year's Muscular Dystrophy Association (MDA) meeting, which will feature discussions on the latest gene therapies, clinical trial data, policy considerations, and more in the realm of neuromuscular disease.
Read More